Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000319514 | SCV000340715 | uncertain significance | not provided | 2016-05-19 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001127365 | SCV001286672 | uncertain significance | Osteogenesis imperfecta | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001127366 | SCV001286673 | uncertain significance | Ehlers-Danlos syndrome, arthrochalasia type | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001127367 | SCV001286674 | uncertain significance | Infantile cortical hyperostosis | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Labcorp Genetics |
RCV001296479 | SCV001485445 | likely benign | Osteogenesis imperfecta type I | 2024-11-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000319514 | SCV001824237 | uncertain significance | not provided | 2020-07-28 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not located in the triple helical region, where the majority of pathogenic missense variants occur (Stenson et al., 2014); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 287066; Landrum et al., 2016) |
Ambry Genetics | RCV002348009 | SCV002622523 | uncertain significance | Cardiovascular phenotype | 2025-02-28 | criteria provided, single submitter | clinical testing | The p.I1245F variant (also known as c.3733A>T), located in coding exon 48 of the COL1A1 gene, results from an A to T substitution at nucleotide position 3733. The isoleucine at codon 1245 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV000319514 | SCV004224398 | uncertain significance | not provided | 2023-01-26 | criteria provided, single submitter | clinical testing |